Funding Rounds
Gesynta Pharma Series C (2020, $20M)
Gesynta PharmaDeveloper of therapies for treating chronic inflammatory conditions.
Summary
Stage: Series C
Raised Amount: $20.55M
Raised Date: 2020-01-01
Stage: Series C
Raised Amount: $20.55M
Raised Date: 2020-01-01
